Bactolife, based in Copenhagen, Denmark, is a biotech company pioneering non-pharmaceutical solutions to support gut health and reduce antibiotic use. Their proprietary Binding Proteins target and neutralize bacterial toxins in the gut, offering a new approach to preventing infections without harming beneficial microbiota.
Bactolife’s innovations are used in food, feed, and supplements—positioning the company outside the traditional pharmaceutical space, with faster regulatory pathways and broader market access. Their work focuses on combating antimicrobial resistance, improving digestion, and enhancing overall health for humans and animals.
Through strategic partnerships and a strong scientific foundation, Bactolife is scaling its technology globally to address pressing health challenges sustainably. Their mission is to create safe, effective, and scalable health solutions that work with the body’s natural systems, not against them, using cutting-edge industrial biotechnology.
